Curbing the Emergence of Clonal Drift in Stem Cell Expansion Culture

抑制干细胞扩增培养中克隆漂移的出现

• 批准号: RGPIN-2020-04198
• 负责人: Shakiba, Nika
• 金额: $ 2.7万
• 依托单位: University of British Columbia
• 依托单位国家: 加拿大
• 项目类别: Discovery Grants Program - Individual
• 财政年份: 2020
• 资助国家: 加拿大
• 起止时间: 2020-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=716837
• 关键词: Curbing; Emergence; Clonal; Drift; Stem

Literature and Recent Progress As evolution guided the development of multicellular organisms, single cells adapted their social interactions to co-operate with one another. Nevertheless, remnants of natural selection remain cells with higher fitness eliminate their relatively weak neighbours. Cell competition has been shown to play a significant role in the growth and repair of tissues, impacting organism survival as a whole. Cancer cells are an example of super-competitors, overtaking communal resources and out-competing the body's normal cells. Much as cancer cells emerge as “cheaters” within our tissues, cell populations grown outside the body are often overtaken by abnormal cells that acquire genetic mutations, giving them a fitness advantage. The emergence of abnormally fit cells continues to plague bioprocesses that aim to derive appropriate and relevant quantities of stem cells and their derivatives for downstream applications. Pluripotent stem cells (PSCs) are particularly powerful given their ability to indefinitely expand (make copies of themselves) and differentiate into all cell types in the body. However, owing to their great expansion potential, PSCs are particularly susceptible to mutations. Objectives and Methodology My long-term objective is to use cell competition as a new lens to reverse-engineer multicellular systems, uncovering how the rules that govern interactions between single cells lead to the success or peril of the whole population. My lab will serve as an interdisciplinary hub, providing mentorship to convergent researchers. By leveraging expertise in computational modeling, stem cells, and synthetic biology, we will design a novel pipeline to better maintain the quality and safety of PSC batches. There are two short-term objectives. First, we will apply a synthetic biology approach to develop a cellular “barcoding” platform to tag PSCs and their progeny with unique DNA identifiers, allowing us to manipulate them based on their barcode. Second, we will track the growth dynamics of each PSC as it expands. By applying a mathematical modeling strategy, we will predict the emergence of PSCs with abnormal fitness and use the active barcode to trigger a suicide switch in these cells, recovering the integrity of the cell batch. HQP I intend to train a diverse group of HQP, including 2 graduate and 5 undergraduate trainees. I will be conscious of using equitable and inclusive recruitment and mentoring practices. Impact The recent boom in the cell therapy sector, including the launch of the Centre for Commercialization of Regenerative Medicine and BlueRock Therapeutics in Canada, have increased the need to produce large quantities of cells. This work addresses a major challenge in the cell manufacturing pipeline, with a novel quality control strategy to maintain cell integrity. Our findings will be broadly applicable to bioprocesses, including protein, virus, and biopharmaceutical production.

文献及最新进展 随着进化引导多细胞生物的发展，单细胞适应了它们的社会相互作用，以相互合作。然而，自然选择的残余仍然是具有较高适应性的细胞淘汰它们相对较弱的邻居。细胞竞争已被证明在组织的生长和修复中发挥重要作用，影响整个生物体的生存。 癌细胞是超级竞争者的一个例子，它们超越了公共资源，并与身体的正常细胞竞争。就像癌细胞在我们的组织中成为“骗子”一样，在体外生长的细胞群通常会被获得基因突变的异常细胞所取代，从而使它们具有适应性优势。异常适应细胞的出现继续困扰旨在获得适当和相关量的干细胞及其衍生物用于下游应用的生物过程。多能干细胞（PSC）特别强大，因为它们能够无限扩增（复制自身）并分化成体内所有细胞类型。然而，由于其巨大的扩增潜力，PSC特别容易发生突变。 目标和方法 我的长期目标是将细胞竞争作为一个新的透镜来逆向工程多细胞系统，揭示管理单细胞之间相互作用的规则如何导致整个群体的成功或危险。 我的实验室将作为一个跨学科的中心，为聚合研究人员提供指导。通过利用计算建模、干细胞和合成生物学方面的专业知识，我们将设计一个新的管道，以更好地保持PSC批次的质量和安全性。有两个短期目标。首先，我们将应用合成生物学方法开发一个细胞“条形码”平台，用独特的DNA标识符标记PSC及其后代，使我们能够根据它们的条形码对其进行操作。其次，我们将跟踪每个PSC的增长动态，因为它扩大。通过应用数学建模策略，我们将预测具有异常适应性的PSC的出现，并使用活性条形码触发这些细胞中的自杀开关，恢复细胞批次的完整性。 HQP 我打算培养一批多元化的HQP，包括2名研究生和5名本科生。我将有意识地使用公平和包容性的招聘和指导做法。 影响 最近细胞治疗领域的蓬勃发展，包括加拿大再生医学商业化中心和BlueRock Therapeutics的推出，增加了生产大量细胞的需求。这项工作解决了细胞制造管道中的一个主要挑战，采用了一种新的质量控制策略来保持细胞的完整性。我们的发现将广泛适用于生物过程，包括蛋白质，病毒和生物制药生产。